Nicotinamide riboside comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms, including bacteria, plants, and mammals. Its structure consists of a nicotinamide ring attached to a ribose-phosphate group. NMN functions as an intermediate in the NAD+ salvage pathway, a recycling route that regenerates nicotinamide adenine dinucleotide. The enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Nucleotide intermediate in NAD+ salvage pathway |
| Common abbreviation | NMN | Also written as β-NMN |
| Molecular formula | C11H15N2O8P | Uncharged parent form |
| Molar mass | 334.22 g/mol | Calculated from formula |
| CAS Registry Number | 1094-61-7 | For β-nicotinamide mononucleotide |
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
Beyond its intracellular synthesis, NMN can be taken up from the extracellular environment, although the routes are still debated. Some evidence points to direct transport into cells through specific transporters, while other work suggests dephosphorylation to nicotinamide riboside followed by cellular uptake. Once inside, NMN can be converted to NAD+ by NMN adenylyltransferases; the relative contribution of these routes may differ by tissue, species, and experimental conditions. Researchers continue to investigate which mechanisms dominate in intact organisms and how they affect measured NAD+ levels. Direct measurement in tissues remains technically challenging because NMN can be rapidly metabolized during sample collection.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
The term NMN commonly refers to the beta isomer, in which the nicotinamide group is attached to the ribose through a beta-glycosidic bond. Commercial material may be supplied as the free acid or as a salt, such as a sodium salt, which affects molecular weight and water solubility. Related compounds include nicotinamide riboside and NAD+ itself, but these are distinct molecules with different formulas and cellular handling. Laboratory research often uses the beta form because it matches the naturally occurring configuration found in biological systems.
Small amounts of NMN occur in some foods, including certain vegetables, fruits, and animal products, though the quantities are generally low and variable. Human cells also synthesize NMN internally from nicotinamide and other precursors. Research interest increased after studies examined whether raising NAD+ levels affects metabolism and aging-related pathways in animals. Evidence in humans remains limited and mixed for many outcomes, and questions about effective absorption, tissue delivery, and long-term effects are still open. Regulatory status differs by country, with some markets treating NMN as a supplement ingredient and others restricting its sale.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
The use of DIAAS would change which plant foods may be marketed as high protein, and thus consumer perception of their dietary choices. The comparison of different sources of protein has implications on both the consumer level and the policy level. Especially as nutrition labels generally describe a food product as sold, they do not necessarily reflect protein quality or changes due to food preparation, so consumers may use measures of protein quality of the food as prepared as an additional source of nutritional guidance. In the developing world, malnutrition may be characterized by a lack of protein. Measuring protein quality may further detail the nature of this malnutrition and have implications for treatment. Additionally, in the context of global development, research on the relative merits of plant and animal proteins takes on an environmental significance, because the trajectory of dietary improvement in developing nations could significantly affect the environment.
{\displaystyle {\begin{aligned}[][a_{0},a_{1},a_{2},a_{3}]&=[0.398942280401,0.159773702775,0.0389687688311,0.00364356495452]\\[][b_{1},b_{2},b_{3},b_{4},b_{5},b_{6}]&=\left[1.653807476138,1.170419428529,0.448892964428,0.0951971709160,0.00931642803836,-6.383774657279\times 10^{-6}\right]\end{aligned}}}
=== Launch === At 8:04:13 a.m. EST, May 15, 1963, Faith 7 was launched from Launch Complex 14. At T+60 seconds, the Atlas started its pitch program. Shortly afterward, MA-9 passed through max Q. At T+2 minutes 14 seconds Cooper felt BECO (Booster Engine Cutoff) and staging. The two Atlas booster engines had been left behind. The Launch Escape Tower was then jettisoned. At T+3 minutes the cabin pressure sealed at 5.5 psi (38 kPa). Cooper reported, "Faith 7 is all go."
Sources: en.wikipedia.org
An application of the Wittig-Still rearrangement in the context of natural product synthesis can be seen in Still's 1979 formal synthesis of the Cecropia juvenile hormone. The organotin-substituted ether that serves as the substrate for the rearrangement was readily prepared by bis-alkylation of the corresponding diol with iodomethyltributyltin. Treatment of this compound with two equivalents of n-butyllithium at low temperature resulted in transmetalation, initiating a double 2,3-sigmatropic rearrangement to give the bis-homoallylic alcohol product in 79% yield. Notably, this rearrangement is highly stereoselective with regard to the geometry of the trisubstituted olefins, giving exclusively the (Z,Z)-isomer shown.
Deputy Director of Adult Social Care, Care Quality Commission. For services to Adult Social Care. Dr. Meenakshi Nagpaul (Meena Thakur). General Practitioner, Honeypot Medical Centre and Clinical Director, Harrow East Primary Care Network. For services to the NHS. Jacqueline Neilson. Chief Executive Officer, Rain Rescue. For services to Animal Welfare. William Lambton Nicholson. Leader, Newbury Working Party Group. For services to Canal Restoration. June Edna Nicol-Dundas. Foster Carer, Fostering London. For services to Young People. Christopher Mansfeldt Norman. Chief Executive and Founder, GOOD Agency. For services to the Business and Charitable Sectors. John Norris. Chair, B&M Longworth (Edgworth) Ltd. For services to Innovation, to Sustainability and to International Trade. Lawrence John O'Halleron. Chair, Big Local Gateshead. For services to the community in Gateshead, Tyne and Wear. Leona O'Neil. Founder, The Boom Foundation. For services to Charitable Fundraising for People with Sarcoma. Harry Clive O'Neill. For charitable services to the community in County Down. Lanré Charles Olagoke. Founder, Art-Alive Arts Trust. For services to Charity and to Young People. David Edward Olney. Assistant Head Ukraine, Security Policy and Operations, Ministry of Defence. For services to Defence. Tori Pamela Anne Olphin. Chief Data Scientist and Head of Research, Thames Valley Police. For services to Technology in the Public Sector. Ehinor Otaigbe-Amedu. For services to Women in Greater Manchester. Lydia Jean Otter.
=== Cultures === Samples undergoing examination for pathogens, primarily in medical microbiology, may be incubated with culture media. Those allow, for example, the description of one or several infectious agents responsible of the clinical signs.
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in the NAD+ salvage pathway. Cells use it to help regenerate NAD+, a coenzyme involved in energy metabolism and cellular signaling. It is present naturally in many organisms and is also produced synthetically for research and consumer products.
NMN is the immediate precursor to NAD+ in the salvage pathway. The enzyme NMN adenylyltransferase adds an adenylate group to NMN to form NAD+. Because NAD+ levels decline with age in some tissues, researchers study whether raising NMN availability can influence NAD+ metabolism.
No. Human evidence is limited, and no regulatory agency has approved NMN for treating or preventing aging. Some trials measure NAD+ metabolites or metabolic markers, but their results do not establish a clinical benefit. Larger, longer studies with standardized endpoints are needed.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in the cellular production of NAD+.